Role of nuclear factor kappaB in cardiovascular health and disease.
暂无分享,去创建一个
Kim Van der Heiden | P. Evans | K. van der Heiden | Mustafa Zakkar | L. Luong | M. Zakkar | S. Cuhlmann | Paul C Evans | Simon Cuhlmann | Le A Luong
[1] P. Evans,et al. NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. , 2008, The Journal of biological chemistry.
[2] Y. Ahn,et al. A20 Is Dynamically Regulated in the Heart and Inhibits the Hypertrophic Response , 2003, Circulation.
[3] Qingbo Xu,et al. Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1-deficient mice. , 2000, Circulation research.
[4] R. Morishita,et al. An initial case of suppressed restenosis with nuclear factor‐kappa B decoy transfection after percutaneous coronary intervention , 2009, The journal of gene medicine.
[5] T. Saito,et al. Cyclooxygenase-2 and nuclear factor-kappaB in myocardium of end stage human heart failure. , 1999, Congestive heart failure.
[6] R. Seth,et al. Ubiquitin, TAK1 and IKK: is there a connection? , 2006, Cell Death and Differentiation.
[7] P. Stenvinkel,et al. Enhanced RAGE-mediated NFκB stimulation in inflamed hemodialysis patients , 2005 .
[8] S. Legrand-Poels,et al. NF-κB activation by reactive oxygen species: Fifteen years later , 2006 .
[9] R. Busse,et al. Endothelial dysfunction in atherosclerosis. , 1996, Journal of vascular research.
[10] M. Kogo,et al. The I&kgr;B Kinase β/Nuclear Factor &kgr;B Signaling Pathway Protects the Heart From Hemodynamic Stress Mediated by the Regulation of Manganese Superoxide Dismutase Expression , 2009, Circulation research.
[11] S. Kihara,et al. Angiotensin II is associated with activation of NF- B- mediated genes and downregulation of PPARs , 2002 .
[12] M. Cybulsky,et al. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] De-Pei Liu,et al. Targeted Cardiac Overexpression of A20 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction , 2007, Circulation.
[14] M. Aoki,et al. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. , 2006, Journal of molecular and cellular cardiology.
[15] A. Koong,et al. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). , 1994, Cancer research.
[16] H. Ploegh,et al. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. , 2004, The Biochemical journal.
[17] Lisheng Zhang,et al. Vein Graft Neointimal Hyperplasia Is Exacerbated by Tumor Necrosis Factor Receptor-1 Signaling in Graft-Intrinsic Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[18] K. Sunagawa,et al. Corrigendum to “Blockade of NF-κB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II” [Cardiovasc Res 67 (2005) 689–698] , 2006 .
[19] P. Evans,et al. The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation , 2008, Journal of Molecular Medicine.
[20] G. Valen,et al. Induction of inflammatory mediators during reperfusion of the human heart. , 2001, The Annals of thoracic surgery.
[21] D. Thomas,et al. Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B , 1995, Molecular and cellular biology.
[22] Gabriel Pineda,et al. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. , 2006, Molecular cell.
[23] T. Evans,et al. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. , 1993, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[24] M. Entman,et al. Nuclear Factor- (cid:1) B Protects the Adult Cardiac Myocyte Against Ischemia-Induced Apoptosis in a Murine Model of Acute Myocardial Infarction , 2022 .
[25] T. Ogihara,et al. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element ‘decoy’ of nuclear factor-kB binding site as a novel molecular strategy , 2001, Gene Therapy.
[26] C. Print,et al. Hypoxia-induced neutrophil survival is mediated by HIF-1α–dependent NF-κB activity , 2005, The Journal of experimental medicine.
[27] M. Gawaz,et al. Transient Platelet Interaction Induces MCP-1 Production by Endothelial Cells via IκB Kinase Complex Activation , 2002, Thrombosis and Haemostasis.
[28] D. Yellon,et al. Ischaemic preconditioning: present position and future directions. , 1998, Cardiovascular research.
[29] G. Bricca,et al. ICAM-1 Deficiency Reduces Atherosclerotic Lesions in Double-Knockout Mice (ApoE−/−/ICAM-1−/−) Fed a Fat or a Chow Diet , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[30] J. Hoch,et al. Vein graft intimal hyperplasia: leukocytes and cytokine gene expression. , 1994, Surgery.
[31] A. M. Lefer,et al. Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium , 1995, Journal of leukocyte biology.
[32] Toby Lawrence,et al. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation , 2005, Nature.
[33] Ebrahim Zandi,et al. Direct Phosphorylation of IκB by IKKα and IKKβ: Discrimination Between Free and NF-κB-Bound Substrate , 1998 .
[34] G. Kollias,et al. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. , 2008, Cell metabolism.
[35] C. Benezra,et al. Induction of tolerance to urushiol by epicutaneous application of this hapten on dinitrofluorobenzene-treated skin. , 1985, The Journal of investigative dermatology.
[36] G. Asimakopoulos. Systemic inflammation and cardiac surgery: an update , 2001, Perfusion.
[37] E. Raines,et al. Thematic Review Series: The Immune System and Atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.R500004-JLR200 , 2005, Journal of Lipid Research.
[38] R. Dietz,et al. Vascular Endothelial Cell–Specific NF-&kgr;B Suppression Attenuates Hypertension-Induced Renal Damage , 2007, Circulation research.
[39] I. Adcock,et al. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. , 2004, Biochemical and biophysical research communications.
[40] T. Deerinck,et al. The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.
[41] L. Casey. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. , 1993, The Annals of thoracic surgery.
[42] R. Dietz,et al. NF- k B activation is required for adaptive cardiac hypertrophy , 2009 .
[43] K. Cunningham,et al. The role of shear stress in the pathogenesis of atherosclerosis , 2005, Laboratory Investigation.
[44] E. R. Taylor,et al. Isolation and characterization of two novel A20-like proteins. , 2001, The Biochemical journal.
[45] G. Dorn. The Fuzzy Logic of Physiological Cardiac Hypertrophy , 2007, Hypertension.
[46] D. Hajjar,et al. Inflammation at the molecular interface of atherogenesis: an anthropological journey. , 2008, The American journal of pathology.
[47] R. Morishita,et al. Initial Clinical Cases of the Use of a NF-κB Decoy at the Site of Coronary Stenting for the Prevention of Restenosis , 2004 .
[48] S. Gerondakis,et al. The FASEB Journal • FJ Express Full-Length Article Absence of NF-�B subunit p50 improves heart failure after myocardial infarction , 2022 .
[49] J. Liao,et al. Inhibition of Endothelial Vascular Cell Adhesion Molecule-1 Expression by Nitric Oxide Involves the Induction and Nuclear Translocation of IκBα* , 1997, The Journal of Biological Chemistry.
[50] M. Hamada,et al. Ischemic preconditioning and lipopolysaccharide attenuate nuclear factor-kappaB activation and gene expression of inflammatory cytokines in the ischemia-reperfused rat heart. , 2001, Japanese circulation journal.
[51] A. Krikos,et al. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. , 1992, The Journal of biological chemistry.
[52] Peihong Ma,et al. Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent manner. , 2005, Blood.
[53] James R. Johnson,et al. Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression , 2004, Science.
[54] J. Cleveland,et al. On-pump coronary artery bypass surgery activates human myocardial NF-κB and increases TNF-α in the heart , 2003 .
[55] Gerard Pasterkamp,et al. Targeted Deletion of Nuclear Factor &kgr;B p50 Enhances Cardiac Remodeling and Dysfunction Following Myocardial Infarction , 2009, Circulation research.
[56] M. E. Ritchie. Nuclear Factor-κB Is Selectively and Markedly Activated in Humans With Unstable Angina Pectoris , 1998 .
[57] E. Schiffrin,et al. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. , 2007, Clinical science.
[58] T. Blundell,et al. A Novel Type of Deubiquitinating Enzyme* , 2003, Journal of Biological Chemistry.
[59] S. Beske,et al. Nuclear Factor-&kgr;B Activation Contributes to Vascular Endothelial Dysfunction via Oxidative Stress in Overweight/Obese Middle-Aged and Older Humans , 2009, Circulation.
[60] R. Knuechel,et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. , 1996, The Journal of clinical investigation.
[61] I. van der Made,et al. Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype. , 2004, Blood.
[62] R. Ross,et al. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[63] L. Hovgaard,et al. Inhibition of Tumor Necrosis Factor-&agr; Reduces Atherosclerosis in Apolipoprotein E Knockout Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[64] Dong-Hoon Shin,et al. Inhibitor of nuclear factor‐kappaB alpha derepresses hypoxia‐inducible factor‐1 during moderate hypoxia by sequestering factor inhibiting hypoxia‐inducible factor from hypoxia‐inducible factor 1α , 2009, The FEBS journal.
[65] M. Sunamori,et al. Cytokinetic study of aortocoronary bypass vein grafts in place for less than six months. , 1991, The American journal of cardiology.
[66] T. Kodama,et al. Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[67] P. Libby,et al. The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human Atherosclerosis* , 1997, The Journal of Biological Chemistry.
[68] Yasushi Matsumura,et al. Involvement of Nuclear Factor-&kgr;B and Apoptosis Signal-Regulating Kinase 1 in G-Protein–Coupled Receptor Agonist–Induced Cardiomyocyte Hypertrophy , 2002, Circulation.
[69] J. Vincent,et al. Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study. , 1999, The Annals of thoracic surgery.
[70] M. Cybulsky,et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. , 2001, The Journal of clinical investigation.
[71] N. Maulik,et al. Reactive oxygen species function as second messenger during ischemic preconditioning of heart , 1999, Molecular and Cellular Biochemistry.
[72] N. Nara,et al. NICORANDIL ATTENUATES NF-κB ACTIVATION, ADHESION MOLECULE EXPRESSION, AND CYTOKINE PRODUCTION IN PATIENTS WITH CORONARY ARTERY BYPASS SURGERY , 2005, Shock.
[73] M. Aoki,et al. Long‐term follow up of initial clinical cases with NF‐κB decoy oligodeoxynucleotide transfection at the site of coronary stenting , 2008, The journal of gene medicine.
[74] K. Rajewsky,et al. Inhibition of NF-κ B activation in macrophages increases atherosclerosis in LDL receptor – deficient mice , 2003 .
[75] P. Libby. Inflammation in Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[76] Guoping Wang,et al. Ischaemia/reperfusion induced cardiac stem cell homing to the injured myocardium by stimulating stem cell factor expression via NF‐κB pathway , 2009, International journal of experimental pathology.
[77] E. Cummins,et al. Hypoxia activates NF-kappaB-dependent gene expression through the canonical signaling pathway. , 2009, Antioxidants & redox signaling.
[78] R. Jennings,et al. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.
[79] E J Topol,et al. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. , 1998, Circulation.
[80] R. Hynes,et al. The combined role of P- and E-selectins in atherosclerosis. , 1998, The Journal of clinical investigation.
[81] M. Quintel,et al. Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery. , 2007, The Annals of thoracic surgery.
[82] J. Starkopf,et al. Hyperoxia elicits myocardial protection through a nuclear factor kappaB-dependent mechanism in the rat heart. , 2003, The Journal of thoracic and cardiovascular surgery.
[83] H. Adelsberger,et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. , 1998, Circulation.
[84] D. Harrison,et al. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[85] D. Agrawal,et al. Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia , 2006, Immunology and cell biology.
[86] David Baltimore,et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.
[87] J. Ramirez,et al. Requirement for NF-κB in Transcriptional Activation of Monocyte Chemotactic Protein 1 by Chlamydia pneumoniae in Human Endothelial Cells , 2000, Infection and Immunity.
[88] Seamus J. Martin,et al. Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.
[89] I. Charo,et al. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.
[90] G. Breithardt,et al. Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support. , 2002, Cardiovascular research.
[91] J. Krieger,et al. Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity. , 2000, Free radical biology & medicine.
[92] P. Kuppusamy,et al. Role of oxygen in postischemic myocardial injury. , 2007, Antioxidants & redox signaling.
[93] Hui Xue,et al. Functional polymorphism of the NFKB1 gene promoter is related to the risk of dilated cardiomyopathy , 2009, BMC Medical Genetics.
[94] C C Canver,et al. Conduit options in coronary artery bypass surgery. , 1995, Chest.
[95] J. Pearl,et al. Modulation of nuclear factor-kappaB improves cardiac dysfunction associated with cardiopulmonary bypass and deep hypothermic circulatory arrest* , 2009, Critical care medicine.
[96] Andreas Schober,et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E , 2003, Nature Medicine.
[97] MasatsuguHori,et al. Involvement of Nuclear Factor-κB and Apoptosis Signal-Regulating Kinase 1 in G-Protein–Coupled Receptor Agonist–Induced Cardiomyocyte Hypertrophy , 2002 .
[98] A. Lin,et al. Activation of nuclear factor- B is necessary for myotrophin-induced cardiac hypertrophy , 2002 .
[99] R. Dietz,et al. Requirement of Nuclear Factor-&kgr;B in Angiotensin II– and Isoproterenol-Induced Cardiac Hypertrophy In Vivo , 2005, Circulation.
[100] Jason Partridge,et al. Laminar shear stress acts as a switch to regulate divergent functions of NF‐κB in endothelial cells , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[101] S. Kaul,et al. Nuclear factor-κB activity and arterial response to balloon injury , 1997 .
[102] P. Libby,et al. Inflammation and Atherosclerosis , 2002, Circulation.
[103] S. Ghosh,et al. Shared Principles in NF-κB Signaling , 2008, Cell.
[104] T. Warner,et al. Macrophage depletion alters vein graft intimal hyperplasia. , 1999, Surgery.
[105] G. Hansson,et al. Unstable angina activates myocardial heat shock protein 72, endothelial nitric oxide synthase, and transcription factors NFkappaB and AP-1. , 2000, Cardiovascular research.
[106] A. Hoffmann,et al. Transcriptional regulation via the NF-κB signaling module , 2006, Oncogene.
[107] N. Cheshire,et al. Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[108] Peter Libby,et al. Inflammation in Atherosclerosis : From Vascular Biology to Biomarker Discovery and Risk Prediction , 2007 .
[109] T. Ogihara,et al. In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction , 1997, Nature Medicine.
[110] T. Loop,et al. Reduced pulmonary inflammatory response during cardiopulmonary bypass: effects of combined pulmonary perfusion and carbon monoxide inhalation. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[111] David Baltimore,et al. Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.
[112] S. Mohan,et al. Differential activation of NF-kappa B in human aortic endothelial cells conditioned to specific flow environments. , 1997, The American journal of physiology.
[113] M. Hori,et al. Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy. , 2002, Journal of molecular and cellular cardiology.
[114] J. Vincent,et al. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. , 1997, Chest.
[115] G. Garcı́a-Cardeña,et al. Early adaptive responses of the vascular wall during venous arterialization in mice. , 2004, The American journal of pathology.
[116] S. Solomon,et al. Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling. , 2004, Journal of the American College of Cardiology.
[117] J. Vinten-johansen,et al. Myocardial protection in reperfusion with postconditioning , 2005, Expert review of cardiovascular therapy.
[118] F. Hernández-Sánchez,et al. NF-κB signaling blockade by Bay 11-7085 during early cardiac morphogenesis induces alterations of the outflow tract in chicken heart , 2006, Apoptosis.
[119] G. Ghosh,et al. Regulation of DNA binding by Rel/NF-κB transcription factors: structural views , 1999, Oncogene.
[120] G. Bricca,et al. ICAM-1 Deficiency Reduces Atherosclerotic Lesions in Double-Knockout Mice (ApoE−/−/ICAM-1−/−) Fed a Fat or a Chow Diet , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[121] G. Ertl,et al. S ustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure , 2003 .
[122] M. Al Banchaabouchi,et al. Antioxidant Amelioration of Dilated Cardiomyopathy Caused by Conditional Deletion of NEMO/IKK&ggr; in Cardiomyocytes , 2010, Circulation research.
[123] T. Mak,et al. Activation of noncanonical NF-κB requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2, TRAF3 and the kinase NIK , 2008, Nature Immunology.
[124] M. Hofker,et al. Nuclear Factor &kgr;B Signaling in Atherogenesis , 2005 .
[125] T. Sawamura,et al. Oxidized Low Density Lipoprotein (ox-LDL) Binding to ox-LDL Receptor-1 in Endothelial Cells Induces the Activation of NF-κB through an Increased Production of Intracellular Reactive Oxygen Species* , 2000, The Journal of Biological Chemistry.
[126] A. Hoffmann,et al. The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .
[127] R. Bolli,et al. Nuclear Factor- (cid:107) B Plays an Essential Role in the Late Phase of Ischemic Preconditioning in Conscious Rabbits , 2022 .
[128] David L. Williams,et al. NF-κB activation is required for the development of cardiac hypertrophy in vivo , 2004 .
[129] F. Mach,et al. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. , 2005, Cardiovascular research.
[130] Somasekar Seshagiri,et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.
[131] K. Webster. Therapeutic angiogenesis , 2007, Cardiovascular Toxicology.
[132] A. Newby. Metalloproteinase Expression in Monocytes and Macrophages and its Relationship to Atherosclerotic Plaque Instability , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[133] T. Rogers,et al. Regulating the regulator: NF-kappaB signaling in heart. , 2006, Journal of molecular and cellular cardiology.
[134] H. Kamata,et al. Hydrogen peroxide activates IκB kinases through phosphorylation of serine residues in the activation loops , 2002, FEBS letters.
[135] A. Farr,et al. An essential role for NF-κB in the cardioadaptive response to ischemia , 1999 .
[136] Sujay K. Singh,et al. Hydrogen Peroxide Activates NF-κB through Tyrosine Phosphorylation of IκBα and Serine Phosphorylation of p65 , 2003, Journal of Biological Chemistry.
[137] D. Nelson,et al. Preoperative glucocorticoids decrease pulmonary hypertension in piglets after cardiopulmonary bypass and circulatory arrest. , 2004, Annals of Thoracic Surgery.
[138] R. Prêtre,et al. Endothelial cell injury in cardiac surgery: salicylate may be protective by reducing expression of endothelial adhesion molecules. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[139] T. Mayadas,et al. Absence of P-selectin delays fatty streak formation in mice. , 1997, The Journal of clinical investigation.
[140] A. Beaudet,et al. P-Selectin or Intercellular Adhesion Molecule (Icam)-1 Deficiency Substantially Protects against Atherosclerosis in Apolipoprotein E–Deficient Mice , 2000, The Journal of experimental medicine.
[141] H. Wong,et al. Sesquiterpene Lactone Parthenolide, an Inhibitor of I&kgr;B Kinase Complex and Nuclear Factor-&kgr;B, Exerts Beneficial Effects in Myocardial Reperfusion Injury , 2002, Shock.
[142] J. Nielsen,et al. Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity , 2006, Proceedings of the National Academy of Sciences.
[143] Keith W. Jones,et al. Cardiac-specific Abrogation of NF- κ B Activation in Mice by Transdominant Expression of a Mutant Iκ B α , 2001 .
[144] F. Ruschitzka,et al. Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia , 2007, Heart.
[145] B. Zuckerbraun,et al. Overexpression of mutated IκBα inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation , 2003 .
[146] A. Murphy,et al. Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules. , 2008, Atherosclerosis.
[147] G. Courtois,et al. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination , 2003, Nature.
[148] I. Adcock,et al. Hydrogen Peroxide Prolongs Nuclear Localization of NF-κB in Activated Cells by Suppressing Negative Regulatory Mechanisms* , 2008, Journal of Biological Chemistry.
[149] P. Libby,et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.
[150] T. Warner,et al. Monocyte chemotactic protein-1 expression is associated with the development of vein graft intimal hyperplasia. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[151] K M Taylor,et al. The systemic inflammatory response syndrome and cardiopulmonary bypass. , 2005, International journal of surgery.
[152] J. Egido,et al. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. , 1997, Circulation.